VSee Enterprise Value Over E B I T D A from 2010 to 2024

VSEEW Stock   0.06  0.03  92.31%   
VSee Health, Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA will likely drop to -81.63 in 2024. During the period from 2010 to 2024, VSee Health, Enterprise Value Over EBITDA regression line of quarterly data had r-squared of  0.60 and coefficient of variation of (56.18). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(77.74)
Current Value
(81.63)
Quarterly Volatility
1.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check VSee Health, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VSee Health,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 449.8 K, Interest Expense of 38.5 K or Selling General Administrative of 6.6 M, as well as many indicators such as Price To Sales Ratio of 24.94, Dividend Yield of 0.0 or Days Sales Outstanding of 22.23. VSee financial statements analysis is a perfect complement when working with VSee Health, Valuation or Volatility modules.
  
Check out the analysis of VSee Health, Correlation against competitors.
For more information on how to buy VSee Stock please use our How to Invest in VSee Health, guide.

Latest VSee Health,'s Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of VSee Health, over the last few years. It is VSee Health,'s Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VSee Health,'s overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

VSee Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(2,852)
Coefficient Of Variation(56.18)
Mean Deviation1,359
Median(3,778)
Standard Deviation1,602
Sample Variance2.6M
Range3.7K
R-Value0.78
Mean Square Error1.1M
R-Squared0.60
Significance0.0007
Slope277.62
Total Sum of Squares35.9M

VSee Enterprise Value Over E B I T D A History

2024 -81.63
2023 -77.74
2022 -139.44
2021 -913.29

About VSee Health, Financial Statements

VSee Health, investors use historical fundamental indicators, such as VSee Health,'s Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in VSee Health,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(77.74)(81.63)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for VSee Stock Analysis

When running VSee Health,'s price analysis, check to measure VSee Health,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VSee Health, is operating at the current time. Most of VSee Health,'s value examination focuses on studying past and present price action to predict the probability of VSee Health,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VSee Health,'s price. Additionally, you may evaluate how the addition of VSee Health, to your portfolios can decrease your overall portfolio volatility.